Investor
Julien Pham, founder and managing partner of Third Culture Capital, discusses 3CC's quest to invest in founders from various backgrounds and help the companies prosper.
Dr. Jay Bhatt, managing director at Deloitte, warns that without high-quality algorithms technology has the potential to increase health inequities and drive mistrust.
The company is fighting to stay afloat amid growing losses and instability.
The company, cofounded by Tony Robbins and backed by Serena Williams, will use the funds to speed up growth and expand its offerings.
HIMSS23
Dr. Hans Kluge, regional director for Europe at WHO, discusses the need for collaboration between public health workers and technology vendors around the world to improve public trust and health equity.
The prescription digital therapeutics company's assets were sold to four bidders: Click Therapeutics, Harvest BIO, Nox Health Group and Welt.
It is now looking to expand into other regions such as the Middle East.
The company says its LLM has passed over 100 healthcare certifications and surpassed GPT-4 and other commercial models’ performance.
HIMSS23
Grady Burrows, executive director of HIT in the CLE, talks about creating a demand-driven model for diverse, local IT teams and his work with colleges and employers to build a career pipeline for youth.
Video game-based therapeutic company Akili and baby tech company Owlet also post first quarter results.